Browse > Article
http://dx.doi.org/10.3904/kjim.2014.29.4.409

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods  

Kanai, Takanori (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)
Matsuoka, Katsuyoshi (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)
Naganuma, Makoto (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)
Hayashi, Atsushi (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)
Hisamatsu, Tadakazu (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)
Publication Information
The Korean journal of internal medicine / v.29, no.4, 2014 , pp. 409-415 More about this Journal
Abstract
The incidence and prevalence of inflammatory bowel diseases (IBDs) including ulcerative colitis and Crohn disease are rapidly increasing in Western countries and in developed Asian countries. Although biologic agents targeting the immune system have been effective in patients with IBD, cessation of treatment leads to relapse in the majority of patients, suggesting that intrinsic immune dysregulation is an effect, not a cause, of IBD. Dramatic changes in the environment, resulting in the dysregulated composition of intestinal microbiota or dysbiosis, may be associated with the fundamental causes of IBD. Japan now has upgraded water supply and sewerage systems, as well as dietary habits and antibiotic overuse that are similar to such features found in developed Western countries. The purpose of this review article was to describe the association of diet, particularly Japanese food and microbiota, with IBD.
Keywords
Diet; Microbiota; Inflammatory bowel diseases; Probiotics; Japanese food;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Spooren CE, Pierik MJ, Zeegers MP, Feskens EJ, Masclee AA, Jonkers DM. Review article: the association of diet with onset and relapse in patients with inf lammatory bowel disease. Aliment Pharmacol Ther 2013;38:1172-1187.   DOI   ScienceOn
2 Hou JK, Lee D, Lewis J. Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol 2013 Oct 6 [Epub]. http://dx.doi.org/10.1016/j.cgh.2013.09.06.
3 Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131:33-45.   DOI   ScienceOn
4 Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013;145:970-977.   DOI   ScienceOn
5 Devkota S, Chang EB. Nutrition, microbiomes, and intestinal inf lammation. Curr Opin Gastroenterol 2013;29:603-607.   DOI
6 Veldhoen M, Brucklacher-Waldert V. Dietary influences on intestinal immunity. Nat Rev Immunol 2012;12:696-708.   DOI   ScienceOn
7 Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031.   DOI   ScienceOn
8 Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-341.   DOI   ScienceOn
9 Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013;500:232-236.   DOI   ScienceOn
10 Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe- derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013;504:446-450.   DOI   ScienceOn
11 Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504:451-455.   DOI   ScienceOn
12 Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013;341:569-573.   DOI   ScienceOn
13 van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-415.   DOI   ScienceOn
14 Hayashi A, Sato T, Kamada N, et al. A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe 2013;13:711-722.   DOI   ScienceOn
15 Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012;487:104-108.   DOI
16 Takaishi H, Matsuki T, Nakazawa A, et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inf lammatory bowel disease. Int J Med Microbiol 2008;298:463-472.   DOI   ScienceOn
17 Kahn SA, Vachon A, Rodriquez D, et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis 2013;19:1506-1513.   DOI
18 Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013;145:946-953.   DOI   ScienceOn
19 Japan Intractable Diseases Information Center. Annual report 2012 from Japan Intractable Diseases Information Center [Internet]. [place unknown]: Japan Intractable Diseases Information Center, 2014 [cited 2014 May 1]. Available from: http://www.nanbyou.or.jp/entry/1356.
20 Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inf lammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.   DOI   ScienceOn
21 Asakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? J Gastroenterol Hepatol 2008;23:1794-1801.   DOI   ScienceOn
22 Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med 2011;365:1713-1725.   DOI   ScienceOn
23 Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.   DOI   ScienceOn
24 Aujnarain A, Mack DR, Benchimol EI. The role of the environment in the development of pediatric inf lammatory bowel disease. Curr Gastroenterol Rep 2013;15:326.   DOI   ScienceOn
25 Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012;9:599-608.   DOI   ScienceOn
26 Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol 2013;48:315-321.   DOI   ScienceOn
27 Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014;49:785-798.   DOI   ScienceOn
28 Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014;146:1489-1499.   DOI   ScienceOn
29 Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011;334:105-108.   DOI   ScienceOn
30 Kaur N, Chen CC, Luther J, Kao JY. Intestinal dysbiosis in inf lammatory bowel disease. Gut Microbes 2011;2:211-216.   DOI   ScienceOn
31 Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 2013;62:1505-1510.   DOI   ScienceOn
32 Neuman MG, Nanau RM. Inf lammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012;160:29-44.   DOI   ScienceOn
33 Sommer F, Backhed F. The gut microbiota: masters of host development and physiology. Nat Rev Microbiol 2013;11:227-238.   DOI   ScienceOn
34 Cho I, Yamanishi S, Cox L, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012;488:621-626.   DOI   ScienceOn
35 Ivanov, II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe 2012;12:496-508.   DOI   ScienceOn
36 Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012;486:215-221.   DOI   ScienceOn
37 Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012;148:1258-1270.   DOI   ScienceOn
38 Blaser M, Bork P, Fraser C, Knight R, Wang J. The microbiome explored: recent insights and future challenges. Nat Rev Microbiol 2013;11:213-217.   DOI   ScienceOn
39 Blumberg R, Powrie F. Microbiota, disease, and back to health: a metastable journey. Sci Transl Med 2012;4:137rv137.
40 Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 2011;9:279-290.   DOI   ScienceOn
41 McCarthy JJ, McLeod HL, Ginsburg GS. Genomic medicine: a decade of successes, challenges, and opportunities. Sci Transl Med 2013;5:189sr184.
42 Kamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013;13:321-335.   DOI   ScienceOn
43 Tyler AD, Smith MI, Silverberg MS. Analyzing the human microbiome: a "how to" guide for physicians. Am J Gastroenterol 2014 Apr 22 [Epub]. http://dx.doi. org/10.1038/ajg.2014.73.
44 Cox MJ, Cookson WO, Moffatt MF. Sequencing the human microbiome in health and disease. Hum Mol Genet 2013;22(R1):R88-R94.   DOI   ScienceOn
45 Weinstock GM. Genomic approaches to studying the human microbiota. Nature 2012;489:250-256.   DOI   ScienceOn
46 Sweeney TE, Morton JM. The human gut microbiome: a review of the effect of obesity and surgically induced weight loss. JAMA Surg 2013;148:563-569.   DOI   ScienceOn
47 Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet 2012;13:260-270.   DOI
48 Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-323.   DOI   ScienceOn
49 Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-176.   DOI
50 Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012;10:735-742.   DOI   ScienceOn
51 Power SE, O'Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr 2014;111:387-402.   DOI
52 Walsh CJ, Guinane CM, O'Toole PW, Cotter PD. Benef icial modulation of the gut microbiota. FEBS Lett 2014 Mar 26 [Epub]. http://dx.doi.org/10.1016/j.febslet. 2014.03.035.
53 De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010;107:14691-14696.   DOI   ScienceOn
54 Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-546.   DOI   ScienceOn
55 Holmes E, Li JV, Marchesi JR, Nicholson JK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab 2012;16:559-564.   DOI   ScienceOn
56 Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science 2012;336:1262-1267.   DOI   ScienceOn
57 Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-227.
58 D'Haens GR, Sartor RB, Silverberg MS, Petersson J, Rutgeerts P. Future directions in inf lammatory bowel disease management. J Crohns Colitis 2014 Apr 14 [Epub]. http://dx.doi.org/10.1016/j.crohns.2014.02.025.
59 Richman E, Rhodes JM. Review article: evidence-based dietary advice for patients with inf lammatory bowel disease. Aliment Pharmacol Ther 2013;38:1156-1171.   DOI   ScienceOn
60 Guarner F. Hygiene, microbial diversity and immune regulation. Curr Opin Gastroenterol 2007;23:667-672.   DOI   ScienceOn